These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 34225831)

  • 1. What makes the psychosis 'clinical high risk' state risky: psychosis itself or the co-presence of a non-psychotic disorder?
    Hasmi L; Pries LK; Ten Have M; de Graaf R; van Dorsselaer S; Bak M; Kenis G; Richards A; Lin BD; O'Donovan MC; Luykx JJ; Rutten BPF; Guloksuz S; van Os J
    Epidemiol Psychiatr Sci; 2021 Jul; 30():e53. PubMed ID: 34225831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'False-positive' self-reported psychotic experiences in the general population: an investigation of outcome, predictive factors and clinical relevance.
    van der Steen Y; Myin-Germeys I; van Nierop M; Ten Have M; de Graaf R; van Dorsselaer S; van Os J; van Winkel R
    Epidemiol Psychiatr Sci; 2019 Oct; 28(5):532-543. PubMed ID: 29656729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity of Incident Diagnostic Outcomes in Patients at Clinical High Risk for Psychosis.
    Webb JR; Addington J; Perkins DO; Bearden CE; Cadenhead KS; Cannon TD; Cornblatt BA; Heinssen RK; Seidman LJ; Tarbox SI; Tsuang MT; Walker EF; McGlashan TH; Woods SW
    Schizophr Bull; 2015 Sep; 41(5):1066-75. PubMed ID: 26272875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CCC2000 Birth Cohort Study of Register-Based Family History of Mental Disorders and Psychotic Experiences in Offspring.
    Jeppesen P; Larsen JT; Clemmensen L; Munkholm A; Rimvall MK; Rask CU; van Os J; Petersen L; Skovgaard AM
    Schizophr Bull; 2015 Sep; 41(5):1084-94. PubMed ID: 25452427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of preceding psychosis risk states and non-psychotic mental disorders with incidence of clinical psychosis in the general population: a prospective study in the NEMESIS-2 cohort.
    Guloksuz S; Pries LK; Ten Have M; de Graaf R; van Dorsselaer S; Klingenberg B; Bak M; Lin BD; van Eijk KR; Delespaul P; van Amelsvoort T; Luykx JJ; Rutten BPF; van Os J
    World Psychiatry; 2020 Jun; 19(2):199-205. PubMed ID: 32394548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DSM outcomes of psychotic experiences and associated risk factors: 6-year follow-up study in a community-based sample.
    Kırlı U; Binbay T; Drukker M; Elbi H; Kayahan B; Keskin Gökçelli D; Özkınay F; Onay H; Alptekin K; van Os J
    Psychol Med; 2019 Jun; 49(8):1346-1356. PubMed ID: 30101737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of psychotic depression - systematic review and meta-analysis.
    Jääskeläinen E; Juola T; Korpela H; Lehtiniemi H; Nietola M; Korkeila J; Miettunen J
    Psychol Med; 2018 Apr; 48(6):905-918. PubMed ID: 28893329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Accuracy of DSM-5 Attenuated Psychosis Syndrome in Adolescents: Prospective Real-World 5-Year Cohort Study.
    Mensi MM; Molteni S; Iorio M; Filosi E; Ballante E; Balottin U; Fusar-Poli P; Borgatti R
    Schizophr Bull; 2021 Oct; 47(6):1663-1673. PubMed ID: 33939829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axis I diagnoses and transition to psychosis in clinical high-risk patients EPOS project: prospective follow-up of 245 clinical high-risk outpatients in four countries.
    Salokangas RK; Ruhrmann S; von Reventlow HG; Heinimaa M; Svirskis T; From T; Luutonen S; Juckel G; Linszen D; Dingemans P; Birchwood M; Patterson P; Schultze-Lutter F; Klosterkötter J;
    Schizophr Res; 2012 Jul; 138(2-3):192-7. PubMed ID: 22464922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-rank symptoms and premorbid adjustment in young individuals at increased risk of developing psychosis.
    Morcillo C; Stochl J; Russo DA; Zambrana A; Ratnayake N; Jones PB; Perez J
    Psychopathology; 2015; 48(2):120-6. PubMed ID: 25720419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anxiety in youth at clinical high risk for psychosis.
    McAusland L; Buchy L; Cadenhead KS; Cannon TD; Cornblatt BA; Heinssen R; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; Addington J
    Early Interv Psychiatry; 2017 Dec; 11(6):480-487. PubMed ID: 26456932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The characteristics and clinical outcomes of a pluripotent high-risk group with the potential to develop a diverse range of psychiatric disorders.
    Lee TY; Lee H; Lee J; Lee Y; Rhee SJ; Park DY; Paek MJ; Kim EY; Kim E; Roh S; Jung HY; Kim M; Kim SH; Ahn YM; Ha K; Kwon JS
    J Psychiatr Res; 2024 Jun; 174():237-244. PubMed ID: 38653032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analytic prevalence of comorbid mental disorders in individuals at clinical high risk of psychosis: the case for transdiagnostic assessment.
    Solmi M; Soardo L; Kaur S; Azis M; Cabras A; Censori M; Fausti L; Besana F; Salazar de Pablo G; Fusar-Poli P
    Mol Psychiatry; 2023 Jun; 28(6):2291-2300. PubMed ID: 37296309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annual Research Review: Prevention of psychosis in adolescents - systematic review and meta-analysis of advances in detection, prognosis and intervention.
    Catalan A; Salazar de Pablo G; Vaquerizo Serrano J; Mosillo P; Baldwin H; Fernández-Rivas A; Moreno C; Arango C; Correll CU; Bonoldi I; Fusar-Poli P
    J Child Psychol Psychiatry; 2021 May; 62(5):657-673. PubMed ID: 32924144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outreach and support in South-London (OASIS) 2001-2020: Twenty years of early detection, prognosis and preventive care for young people at risk of psychosis.
    Fusar-Poli P; Spencer T; De Micheli A; Curzi V; Nandha S; McGuire P
    Eur Neuropsychopharmacol; 2020 Oct; 39():111-122. PubMed ID: 32921544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between environmental and familial affective risk impacts psychosis admixture in states of affective dysregulation.
    Radhakrishnan R; Guloksuz S; Ten Have M; de Graaf R; van Dorsselaer S; Gunther N; Rauschenberg C; Reininghaus U; Pries LK; Bak M; van Os J
    Psychol Med; 2019 Aug; 49(11):1879-1889. PubMed ID: 30284529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Course of clinical high-risk states for psychosis beyond conversion.
    Michel C; Ruhrmann S; Schimmelmann BG; Klosterkötter J; Schultze-Lutter F
    Eur Arch Psychiatry Clin Neurosci; 2018 Feb; 268(1):39-48. PubMed ID: 28054132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resurrection of the Follow-Back Method to Study the Transdiagnostic Origins of Psychosis.
    van Os J; Schaub A; Carpenter WT
    Schizophr Bull; 2021 Apr; 47(3):583-585. PubMed ID: 33543754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged exposure and EMDR for PTSD v. a PTSD waiting-list condition: effects on symptoms of psychosis, depression and social functioning in patients with chronic psychotic disorders.
    de Bont PA; van den Berg DP; van der Vleugel BM; de Roos C; de Jongh A; van der Gaag M; van Minnen AM
    Psychol Med; 2016 Aug; 46(11):2411-21. PubMed ID: 27297048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Social Anxiety in individuals with clinical high-risk state for psychosis].
    Haidl TK; Rosen M; Ruhrmann S; Klosterkötter J
    Fortschr Neurol Psychiatr; 2019 May; 87(5):284-297. PubMed ID: 30005443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.